Tafinlar
List of products in the National Drug Code with proprietary name tafinlar. Dabrafenib may be used alone or in combination with another medication (trametinib) to treat a type of skin cancer (melanoma). It is also used with trametinib to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Dabrafenib works by slowing the growth of cancer cells.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0078-0681 | Tafinlar | Dabrafenib | Capsule | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0682 | Tafinlar | Dabrafenib | Capsule | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-1154 | Tafinlar | Dabrafenib | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0173-0846 | Tafinlar | Glaxosmithkline Llc | ||||
| 0173-0847 | Tafinlar | Glaxosmithkline Llc |
